A prospective study of 30 glaucoma patients (one eye in each patient) treated by an ab externo holmium laser sclerostomy is presented. An average of 40.2 pulses with an energy of 100 mJ was necessary to produce a filtering bleb. The average pre-operative intraocular pres sure was 25.5 ± 7.4 mmHg, with an average of 14.06 ± 5.7 mmHg post-operatively at the final fol low-up. The mean follow-up was 7.5 months (range 5-12 months) and the mean age of the patients was 71.4 years. Using strict criteria 70% of sclerostomies were con sidered successful at the final follow-up visit. The main post-operative complication was iris plugging of the scler ostomy. This was dealt with successfully with a 'Q'-switched neodymium:YAG laser in 80% of cases.
The THC: Y AG laser is a solid state infrared laser with a wavelength of 2100 nm. Thulium and chromium are used as sensitisers which improve the efficiency of the laser, holmium is the active element and the solid crystal doped is yttrium aluminium garnet (YAG). The laser energy is delivered at the end of a 22 gauge (712 Ilm) probe, at 90° to the long axis of the probe. A helium-neon (HeNe) aim ing beam is used for orientation. The mechanism of pro duction of a sclerostomy is by the interaction of the infrared laser radiation and water absorption of the cor neoscleral tissue. The procedure involves less conjunc tival manipulation and consequently less post-operative inflammation and scarring compared with conventional filtering procedures.
We present our early experience with the use of this laser, the complications encountered and their management. 
MATERIALS AND METHODS
Patients who were scheduled to undergo glaucoma fil tering surgery were offered enrolment in the study. The inclusion criteria were failure of maximally tolerated medical therapy with or without previous argon laser tra beculoplasty, an intraocular pressure (lOP) considered unsafe for the degree of optic nerve head damage present, and progressive field loss despite adequate lOP control. Thirty patients underwent the procedure in one eye. Twenty-five patients had primary open angle glaucoma (POAG), 2 had secondary glaucoma after penetrating cor neal grafts, 2 had normal pressure glaucoma (NPG) and 1 had chronic angle closure glaucoma (CACG); 26.7% were pseudophakic and 16% of them had previously failed trabeculectomies.
The mean age of the patients was 71.4 years (range 55-84 years). There were 14 men and 16 women. Tw enty eight patients were Caucasian, 1 was Afro-Caribbean and 1 was Asian.
The pre-operative assessment included visual acuity, lOP (mean of three readings), gonioscopy disc assessment and threshold perimetry using an Octopus programme 34 or the Henson's Field Analyser.
Procedure
All operations were performed by one surgeon (J.A.M.). Topical amethocaine was instilled into the conjunctival sac, and a 3 ml mixture of 2% xylocaine and bupivicaine injected into the retrobulbar space. The patient's eye was cleaned and draped. With the use of an operating micro scope a 1 mm conjunctival incision was made 12 mm away from the limbus, preferably in an area of virgin con junctiva. The probe was calibrated to emit 100 mJ of energy per pulse at 5 pulses per second. The probe was then tunnelled through the conjunctival incision to reach the very limit of the conjunctival insertion at the limbus, and held tangentially so that the HeNe aiming beam pointed towards the centre of the anterior chamber. Laser emission was initiated by pressing a foot pedal. Entry into the anterior chamber was heralded by (1) a change in tone of the laser emission from a dull thumping sound to a (a) (e) sharp cracking sound, (2) the presence of small bubbles in the anterior chamber, (3) the release of pigment into the anterior chamber, (4) the movement of the iris and its pea king when the probe was elevated and (5) the formation of a large bleb when the probe was withdrawn. The laser was fi red again after allowing the iris to prolapse into the scler ostomy, in effect creating an iridotomy. A 10-0 nylon suture was used to close the conjunctival incision. A scleral contact lens was inserted at the end of the procedure.
The average number of pulses needed to complete the procedure was 40.2 (range 17-99). The average total energy was 4.1 joules (range of 1.7-11.2 joules). The scleral contact lens was removed on the first post operative day if the anterior chamber was well formed and the lOP above 5 mmHg. None of the eyes required the scleral contact lens for more than 48 hours. Post-oper atively the eye had a large diffuse bleb, with corneal striae radiating from the site of the sclerostomy; the anterior chamber was about half chamber depth with evidence of stromal iris atrophy and in 50% of cases a full-thickness iridotomy. The early post-operative blebs were large ( Fig. la) , but settled down to a shallow diffuse bleb with a few cystic spaces by 12 months post-operatively (Fig. Ib) ; however, a few patients had a localised cystic bleb (Fig. lc) 12 months post-operatively. There was no particular charac ter to a bleb produced by holmium laser and many resem bled blebs produced by conventional trabeculectomies.
Follow-up visits were carried out on the first post operative day and then every week for a month and every month for 6 months. Visual acuity was tested, lOP measured and gonioscopy performed at every post-oper ative visit to exclude the presence of iris plugging of the sclerostomy. Follow-up ranged from 5 to 12 months.
RESULTS

Complications
The main post-operative complication (46%) was lflS A filtration bleb could not be produced in 1 patient due to formation of an eschar at the site of proposed entry into the anterior chamber; this case went on to trabeculectomy.
Hyphaema was present in 3 patients, subconjunctival haemorrhage in 2 patients, and conjunctival buttonholes in 3 cases, of which 1 was recognised as an aqueous leak post-operatively (the latter sealed spontaneously). The hyphaemas and the subconjunctival haemorrhages dis appeared within the first post-operative week. The con junctival buttonholes recognised during surgery were closed with 10-0 nylon and another site chosen for the sclerostomy.
One patient had a transient rise in lOP on the first post operative day which was resolved with massage of the bleb. All the eyes that had a filtering bleb on the first post operative day had a shallow anterior chamber; none of these eyes required treatment, as full chamber depth was achieved by the first week post-operatively. No eyes had flat anterior chambers in our study.
Success Rates
Our criteria for success included:
1. Desired success: An lOP lowered to a level that was considered safe for that eye in the presence of a functional filter without medication. The patients were divided into three groups depending on the severity of optic nerve head cupping and field loss. The more advanced the glaucoma, the lower was the target pressure post-operatively.
On the first post-operative day all patients in all groups achieved their target lOPs. The results presented are the values at final follow-up. The mean lOP of the qualified successes before medical therapy was added has not con tributed to the value of our data, as the medical therapy was started at different times as and when the lOP went above the target pressure for a patient in that particular group.
In group 1, with advanced optic nerve head cupping and extensive field loss, 12 of 18 (66.6%) came within a target lOP of 12 mmHg (Fig. 3) , of which 10 were desired suc cesses (Table I ) and 2 were qualified successes. The mean lOP was 24.5 ± 8.2 mmHg pre-operatively and 13.1 ± 5.8 mmHg post-operatively at the final follow-up (Fig. 4) . Two failed because of gradual shrinkage of the size of the bleb, probably a result of the sclerostomy open ing being too small. The remaining 4 failures in this group were due to iris incarceration of the sclerostomy which could not resume filtration after treatment with the neo dymium: Y AG laser. The failures in this group went on to have trabeculectomies with 5-fluorouracil therapy. In group 2, with moderate optic nerve head cupping and field loss, 6 of 7 (85.7%) achieved a target lOP of 16 mmHg of which 4 were desired successes and 2 quali fied successes. The mean lOP was 26.2 ± 6.8 mmHg pre operatively and 12.8 ± 4.0 mmHg post-operatively. The 1 failure, despite an lOP within the target level, had no obvious bleb. The pre-operative lOP was 26 mmHg, hence there must have been some occult filtration. The patient continues to be on maximal medical therapy.
In group 3, with early optic nerve head cupping and field loss, 3 of 5 (60%) achieved the target lOP of 18 mmHg, all of which were desired successes. The mean lOP was 28.0 ± 5.3 mmHg pre-operatively and 18 ± 5.9 mmHgpost-operatively. The 2 failures had evi dence of episcleral scarring over the external opening of the sclerostomy when a trabeculectomy was done.
The mean number of medications used pre-operatively was 2.2 ± 0.7; the mean number of medications used post-operatively (as calculated at the final post-operative visit) was 0.8 ± 1.0. Each topical medication was equivalent to a score of 1 point, and diamox was equivalent to a score of 1 point. The details are presented in Table II .
The overall success rate with one holmium procedure was 70%. There was no deterioration of vision in any patient. If the criteria for success used in other studies are followed (i.e. lOP <21 mmHg) the success rate of our study is 83.3%. Of the 30 patients, 17 (56.7%) were desired successes who achieved their target pressures without supplemen tary medical therapy. In these 17 patients the mean lOP pre-operatively with maximally tolerated medical therapy was 25.5 ± 5.5 mmHg and the mean post-operative lOP without supplementary medical therapy was 11.6 ± 4.4 mmHg. The mean post-operative lOP in our study was calculated at 4-6 months after surgery depend ing on the length of follow-up.
DISCUSSION
Since the introduction of trabeculopuncture by Krasnov in 1973 with the use of the ruby laser, I the neodymium: Y AG laser and the argon laser have been used to lower the lOP. However, the effectiveness of these procedures (trabecu lopuncture and trabeculoplasty) decreases with time, so that after 5 years only 30-60% of the cases treated with these modalities maintain a satisfactory IOP?- 4 Filtering blebs have been produced experimentally with the neodymium:YAG laser,S the CO2 laser6 and the excimer laser. 7 The use of the holmium laser in endo- Table II . Mean number of pre-and post-operative medications prompted its use in the production of an ab externo sub conjunctival limbal sclerostomy in rabbits. 10 The holmium laser produces its effects on biological tissues by its coeffi cient of water absorption, which falls between that of the neodymium: Y AG laser and the CO2 laser. As it works to produce a sclerostomy it cauterises the edges of the scler ostomy, minimising bleeding. The laser damage stops when aqueous is encountered, and damage is limited to about 300!lm around the internal opening of the sclerostomy.
Hoskins et al. ll reported their results with the holmium laser in 21 patients with glaucoma. Their criterion for suc cess was an lOP of <22 mmHg or a 30% reduction in lOP. The overall success rate with one holmium laser procedure was 57%, which was increased to 76% with an additional holmium laser procedure in 5 patients. In spite of stricter criteria for a success in our patients, our success rate for a single holmium laser procedure was 70%.
As experience with the use of the laser grew, techniques were introduced to prevent the major complication of iris incarceration of the sclerostomy. These include:
1. Pre-operative measures (ii) The use of healon both to prevent and to treat iris incarceration of the sclerostomy has been described. This manoeuvre was not used in our study. (iii) As the first sclerostomy is completed the probe is pushed onto a new site on the limbus adjacent to the first and another sclerostomy is made. The theory behind this technique is that it may be harder for the iris to incarcerate two sclerostomies in close proximity.
3. Post-operative measures 
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(iii) Use of long-term pilocarpine 2% twice daily. This theoretically tightens the iris plane preventing iris prolapse. In the authors' experience this has not pre vented iris prolapse in all cases as some patients had iris incarceration while on pilocarpine. Pilocarpine in our series was only used initially in the first 6 eyes; however, iris plugging was seen in 3 of these patients while on pilocarpine. It was discontinued after the first week post-operatively. In 24 eyes pilocarpine was not instituted post-operatively as a measure to reduce iris incarcerations.
We conclude that the holmium laser is an effective method of producing a filtering sclerostomy; however, a longer follow-up is required to prove its superiority over or equal ity with other standard filtering procedures. It is easier to perform than other techniques and may be completed as an office procedure. Conjunctival handling is reduced to a minimum. There is no anterior chamber manipulation with this procedure and problems with a post-operative flat anterior chamber have not been encountered. A power of 100-120 mJ is sufficient to create a sclerostomy of a size necessary for long-term filtration (150-200 !lm). However, the ideal size of the sclerostomy has yet to be worked out. This study is continuing and pathological investigations of the specimens from the failed cases that underwent trabecu lectomies should yield information on the size of the scler ostomies that closed spontaneously.
